Skip to main content
Have a personal or library account? Click to login
Irreversible electroporation ablation with bipolar electrodes: ultrasound findings of ablation zones Cover

Irreversible electroporation ablation with bipolar electrodes: ultrasound findings of ablation zones

Open Access
|Apr 2026

References

  1. Pillai K, Akhter J, Chua TC, Shehata M, Alzahrani N, Al-Alem I, et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore) 2015; 94: e580. doi: 10.1097/MD.0000000000000580
  2. Siddiqui IA, Kirks RC, Latouche EL, DeWitt MR, Swet JH, Baker EH, et al. High-frequency irreversible electroporation: safety and efficacy of next-generation irreversible electroporation adjacent to critical hepatic structures. Surg Innov 2017; 24: 276-83. doi: 10.1177/1553350617692202
  3. Siddiqui IA, Latouche EL, DeWitt MR, Swet JH, Kirks RC, Baker EH, et al. Induction of rapid, reproducible hepatic ablations using next-generation, high-frequency irreversible electroporation (H-FIRE) in vivo. HPB (Oxford) 2016; 18: 726-34. doi: 10.1016/j.hpb.2016.06.015
  4. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-31. doi: 10.1007/s10439-005-8981-8
  5. Aycock KN, Campelo SN, Salameh ZS, Davis JMK, Iannitti DA, McKillop IH, et al. Toward large ablations with single-needle high-frequency irreversible electroporation in vivo. IEEE Trans Biomed Eng 2024; 72: 705-15. doi: 10.1109/TBME.2024.3468159
  6. O’Brien TJ, Bonakdar M, Bhonsle S, Neal RE 2nd, Aardema CH Jr, Robertson JL, et al. Effects of internal electrode cooling on irreversible electroporation using a perfused organ model. Int J Hyperthermia 2018; 35: 44-55. doi: 10.1080/02656736.2018.1473893
  7. Wandel A, Ben-David E, Ulusoy BS, Neal R, Faruja M, Nissenbaum I, et al. Optimizing irreversible electroporation ablation with a bipolar electrode. J Vasc Interv Radiol 2016; 27: 1441-50.e2. doi: 10.1016/j.jvir.2016.06.001
  8. Appelbaum L, Ben-David E, Sosna J, Nissenbaum Y, Goldberg SN. US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology 2012; 262: 117-25. doi: 10.1148/radiol.11110475
  9. Ben-David E, Appelbaum L, Sosna J, Nissenbaum I, Goldberg SN. Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol 2012; 198: W62-8. doi: 10.2214/AJR.11.6940
  10. Mehta KS, Lee JJ, Taha AG, Avgerinos E, Chaer RA. Vascular applications of contrast-enhanced ultrasound imaging. J Vasc Surg 2017; 66: 266-74. doi: 10.1016/j.jvs.2016.12.133
  11. Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021; 46: 3579-95. doi: 10.1007/s00261-021-03059-y
  12. Bollen PJ, Nielsen BJ, Toft P. Influence of endotoxin-induced sepsis on the requirements of propofol-fentanyl infusion rate in pigs. Basic Clin Pharmacol Toxicol 2007; 100: 192-6. doi: 10.1111/j.1742-7843.2007.00099.x
  13. Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 2020; 18: e3000410. doi: 10.1371/journal.pbio.3000410
  14. Tendillo FJ, Mascias A, Santos M, de Segura IA, Castillo-Olivares JL. [Cardiorespiratory and analgesic effects of continuous infusion of propofol in swine as experimental animals]. [Spanish]. Rev Esp Anestesiol Reanim 1996; 43: 126-9. PMID: 8815464
  15. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 2010; 110: 1305-9. doi: 10.1213/ANE.0b013e3181d27b30
  16. Lu IC, Tan H, Wu SH, Huang TY, Tseng HY, Wang JJ, Dionigi G, et al. A comparison between cisatracurium and rocuronium-induced neuromuscular block on laryngeal electromyography recovery after neostigmine reversal in a porcine model. Front Endocrinol (Lausanne) 2022; 13: 875597. doi: 10.3389/fendo.2022.875597
  17. Tutunaru A, Dupont J, Huberty V, Ibrahim M, Serteyn D, Sandersen C. Use of cis-atracurium to maintain moderate neuromuscular blockade in experimental pigs. Vet Anaesth Analg 2017; 44: 910-4. doi: 10.1016/j. vaa.2016.09.006
  18. Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, Lu DS. Contrast enhancement patterns after irreversible electroporation: experimental study of CT perfusion correlated to histopathology in normal porcine liver. J Vasc IntervRadiol 2016; 27: 104-11. doi: 10.1016/j.jvir.2015.09.005
  19. Felker ER, Dregely I, Chung DJ, Sung K, Osuagwu FC, Lassman C, et al. Irreversible electroporation: defining the MRI appearance of the ablation zone with histopathologic correlation in a porcine liver model. AJR Am J Roentgenol 2017; 208: 1141-6. doi: 10.2214/AJR.16.17207
  20. Tam AL, Abdelsalam ME, Gagea M, Ensor JE, Moussa M, Ahmed M, et al. Irreversible electroporation of the lumbar vertebrae in a porcine model: is there clinical-pathologic evidence of neural toxicity? Radiology 2014; 272: 709-19. doi: 10.1148/radiol.14132560
  21. Chai W, Xie L, Zhao Q, Cheng C, Tian G, Jiang T, et al. Ultrasound and contrast-enhanced ultrasound findings after percutaneous irreversible electroporation of hepatic malignant tumors. Ultrasound Med Biol 2020; 46: 620-9. doi: 10.1016/j.ultrasmedbio.2019.12.012
  22. Zhou L, Yin S, Chai W, Zhao Q, Tian G, Xu D, et al. Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound. World J Surg Oncol 2020; 18: 305. doi: 10.1186/s12957-020-02083-4
  23. Lin MX, Kuang M, Xu M, Zhuang BW, Tian WS, Ye JY, et al. Ultrasound and contrast-enhanced ultrasound for evaluation of irreversible electroporation ablation: in vivo proof of concept in normal porcine liver. Ultrasound Med Biol 2016; 42: 2639-49. doi: 10.1016/j.ultrasmedbio.2016.07.007
  24. Brloznik M, Boc N, Sersa G, Zmuc J, Gasljevic G, Seliskar A, et al. Radiological findings of porcine liver after electrochemotherapy with bleomycin. Radiol Oncol 2019; 53: 415-26. doi: 10.2478/raon-2019-0049
  25. Brloznik M, Boc N, Cemazar M, Sersa G, Bosnjak M, Brezar SK, et al. Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma. Sci Rep 2021; 11: 13446. doi: 10.1038/s41598-021-92820-w
  26. Brloznik M, Kranjc Brezar S, Boc N, et al. Results of dynamic contrast-enhanced ultrasound correlate with treatment outcome in canine neoplasia treated with electrochemotherapy and interleukin-12 plasmid electrotransfer. Front Vet Sci 2021; 8: 679073. doi: 10.3389/fvets.2021.679073
  27. Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 2010; 255: 426-33. doi: 10.1148/radiol.09090669
  28. Sugimoto K, Moriyasu F, Kobayashi Y, Kasuya K, Nagakawa Y, Tsuchida A, et al. Assessment of various types of US findings after irreversible electroporation in porcine liver: comparison with radiofrequency ablation. J Vasc Interv Radiol 2015; 26: 279-87.e3. doi: 10.1016/j.jvir.2014.11.007
  29. Neal RE 2nd, Rossmeisl JH Jr, Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV. Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 2011; 29: e372-7. doi: 10.1200/JC0.2010.33.0902
  30. Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, et al. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones. J Vasc Interv Radiol 2014; 25: 1589-94. doi: 10.1016/j.jvir.2014.06.026
  31. Vroomen LGPH, Scheffer HJ, Melenhorst MCAM, de Jong MC, van den Bergh JE, van Kuijk C, et al. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation. Eur Radiol 2017; 27: 2521-31. doi: 10.1007/s00330-016-4581-2
  32. Neal RE 2nd, Garcia PA, Kavnoudias H, Rosenfeldt F, McLean CA, Earl V, et al. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models. IEEE Trans Biomed Eng 2015; 62: 561-9. doi: 10.1109/TBME.2014.2360374
  33. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality - clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. doi: 10.1177/153303460700600106
  34. Gurrappa I, Binder L. Electrodeposition of nanostructured coatings and their characterization: a review. Sci Technol Adv Mater 2008; 9: 043001. doi: 10.1088/1468-6996/9/4/043001
  35. Sano MB, Fesmire CC, Petrella RA. Electro-thermal therapy algorithms and active internal electrode cooling reduce thermal injury in high-frequency pulsed electric field cancer therapies. Ann Biomed Eng 2021; 49: 191-202. doi: 10.1007/s10439-020-02524-x
  36. Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep 2019; 9: 3649. doi: 10.1038/s41598-019-40395-y
  37. Dežman R, Čemažar M, Serša G, Seliškar A, Erjavec V, Trotovšek B, et al. Safety and feasibility of electrochemotherapy of the pancreas in a porcine model. Pancreas 2020; 49: 1168-73. doi: 10.1097/MPA.0000000000001642
DOI: https://doi.org/10.2478/raon-2026-0022 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Submitted on: Jan 23, 2026
Accepted on: Mar 3, 2026
Published on: Apr 16, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Linyu Zhou, Qiang Chen, Ju Li, Chengyue Zhang, Shengyong Yin, Min Xu, Tian’an Jiang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

AHEAD OF PRINT